SUBSCRIBE
SUBSCRIBE

Biora Therapeutics

IN THE PRESS
Biotech Beach
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
November 30, 2023
 · 
5 min read
Business
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 13, 2023
 · 
10 min read
Business
Biora Therapeutics to Report Third Quarter 2023 Financial Results and Provide Corporate Update
November 6, 2023
 · 
3 min read
Biotech Beach
Biora Therapeutics Submits Updated IND Application for BT-600
October 30, 2023
 · 
5 min read
Biotech Beach
Biora Therapeutics to Submit Updated IND Application for BT-600
October 23, 2023
 · 
6 min read
Biotech Beach
Biora Therapeutics Presents Data on the BioJet™ Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes
October 5, 2023
 · 
5 min read
Biotech Beach
Biora Therapeutics Announces Submission of IND Application to the U.S. FDA for BT-600 Program
September 25, 2023
 · 
6 min read
Biotech Beach
Biora Therapeutics Reduces Debt and Largest Shareholder Increases Equity Exposure
September 19, 2023
 · 
4 min read
Biotech Beach
Biora Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 11, 2023
 · 
3 min read
Biotech Beach
Biora Therapeutics Progresses its BioJet™ Systemic Oral Delivery PlatformConfirmation of autonomous device function enables progress to testing of pharma collaborators’ molecules
September 5, 2023
 · 
5 min read
Load More
JOBS